Zenta Tsuchihashi

Zenta Tsuchihashi, PhD, currently serves as Senior Director of Translational Patient Safety and Clinical Safety and Pharmacovigilance at Daiichi Sankyo since 2020, with responsibilities including translational science leadership and biomarker analysis for the DS-8201 program. Previous experience includes roles as Senior Medical Science Liaison at AstraZeneca, Director of Medical Affairs at Daiichi Sankyo, Biomarker Program Leader at Novartis, and Group Leader for Immuno-Oncology Biomarkers at Bristol-Myers Squibb. Early career contributions include significant work at Mercator Genetics and Somatix Therapy, as well as a postdoctoral research role at Stanford University. Zenta Tsuchihashi holds a PhD and Bachelor's degree in Pharmaceutical Sciences from The University of Tokyo and completed postdoctoral research in Biochemistry at Stanford University.